Applied Biology, Inc.

This study tests a treatment called DA-001 for reducing hair shedding and helping hair grow back. It includes over 1,100 adults with telogen effluvium or pattern hair loss. Participants will apply the treatment as directed, and researchers will measure changes in hair shedding an…

This study tests a new treatment called DA-020 to prevent hair loss in people with early-stage breast cancer receiving chemotherapy. About 60 participants will use the treatment and be monitored for hair loss during and after chemo. The goal is to see if DA-020 can reduce or prev…

This early-stage study tests a cream called CS-002, which blocks a protein linked to aging, to see if it can safely reverse grey hair. Researchers will enroll 100 healthy adults aged 30 to 65 with grey hair. Participants apply the cream as directed, and doctors will measure chang…

This early-phase study looks at how much of the drug DA-020 gets into the blood after a single application to the scalp. It involves 60 healthy women aged 18-55. The goal is to measure drug levels and check for side effects like blood pressure changes. This is a first step before…